PAR HEALTH
Live / Registered — Registered (as of 20 Oct 2026)
What this means for you
Registered since 20 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 99409684
- Registration number
- 8516992
- Mark type
- Stylized text
- Filed
- 24 Sept 2025
- Published for opposition
- 10 Mar 2026
- Registered
- 20 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 20 Oct 2032 (grace period to 20 Apr 2033)
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely, epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; Pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely, epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatrics, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents
- Class 035 — Advertising and business services: Outsourcing services in the nature of arranging procurement of goods for others in the field of pharmaceuticals; Business administration of patient reimbursement programs for pharmaceuticals; Business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient
- Class 040 — Treatment of materials: Custom manufacture of pharmaceutical products to the order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services
- Class 044 — Medical, beauty and agricultural services: Charitable services, namely, patient assistance programs that provide pharmaceuticals to help patients with low income get pharmaceuticals at little or no cost to the patient
Owner
- PH HEALTH LIMITED, Ballsbridge, Dublin 4, IE
- PH HEALTH LIMITED, Ballsbridge, Dublin 4, IE
- PH HEALTH LIMITED, Ballsbridge, Dublin 4, IE
Prior registrations
Prosecution history
- 20 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Sept 2026 — POST PUBLICATION AMENDMENT - ENTERED
- 28 Sept 2026 — ASSIGNED TO LIE
- 24 Sept 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 18 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 06 May 2026 — USE AMENDMENT FILED
- 18 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 06 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 06 May 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 05 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED